| Name | Chloro[4,4',4'',4'''-(5,10,15,20-porphyrintetrayl-κ2N21,N23)tetrabenzenesulfonato(2-)]iro |
|---|
| Description | FeTPPS, a 5,10,15,20-tetrakis (4-sulfonatophenyl) porphyrin iron III chloride peroxynitrite decomposition catalyst, possessed evident neuroprotective effects in a experimental model of spinal cord damage[1]. FeTPPS acts as a peroxynitrite scavenger and anti-nitrating agent in vivo. FeTPPS reduces nitric oxide (NO) production and apoptosis process[2]. |
|---|---|
| Related Catalog | |
| In Vitro | FeTPPS act as an effective pro-oxidant towards appreciable substrates in vitro in the presence of oxidant. FeTPPS protect cells against oxidative damage induced by H2O2, generated by Glucose (G)-glucose oxidase (GO) system[2]. Cell Viability Assay[2] Cell Line: Human hepatocellular carcinoma (HepG2) Concentration: 5, 10, 15, 20, 25 μM Incubation Time: Treated 12 h before being exposed to H2O2 Result: Could protect cells against oxidative damage induced by H2O2. |
| References |
| Molecular Formula | C44H28ClFeN4O12S4 |
|---|---|
| Molecular Weight | 1024.27 |
| Exact Mass | 1022.96000 |
| PSA | 304.33000 |
| LogP | 7.89130 |